Publication | Closed Access

Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer

Dendritic Cell ImmunotherapyCancer ImmunosurveillanceMedicineImmunologyImmunoeditingTh2 Cytokine ProfileBronchial NeoplasmImmune Checkpoint InhibitorImmunomodulationLung CancerImmunotherapyCytokine-induced Killer CellsRadiation OncologyTumor Microenvironment